CONTENTS:
- Mexico's drug policy reform: Cutting edge success or crisis in the making? [Editorial]. Werb D., Mora M.E.M., Beletsky L., Rafful C., Mackey T., Arredondo J., et al., p. 823-825.
- The addict as victim: Producing the 'problem' of addiction in Australian victims of crime compensation laws. Seear K., Fraser S., p. 826-835.
- Rethinking risk: Gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border. Syvertsen J.L., Robertson A.M., Strathdee S.A., Martinez G., Rangel M.G., Wagner K.D., p. 836-844.
- Within-prison drug injection among HIV-infected Ukrainian prisoners: Prevalence and correlates of an extremely high-risk behaviour. Izenberg J.M., Bachireddy C., Wickersham J.A., Soule M., Kiriazova T., Dvoriak S., et al., p. 845-852.
- An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India. Goswami P., Medhi G.K., Armstrong G., Setia M.S., Mathew S., Thongamba G., et al., p. 853-864.
- How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting. Treloar C., Rance J., p. 865-870.
- Hepatitis C among people who inject drugs in Tbilisi, Georgia: An urgent need for prevention and treatment. Bouscaillou J., Champagnat J., Luhmann N., Avril E., Inaridze I., Miollany V., et al., p. 871-878.
- Selections of reality: Applying Burke's dramatism to a harm reduction program. Järvinen M., Miller G., p. 879-887.
- Promoting family-focused approaches within adult drug services: The potential of the 'Senses Framework'. Orr L.C., Elliott L., Barbour R.S., p. 888-896.
- "In their perception we are addicts": Social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam. Tomori C., Go V.F., Tuan L.N., Huong N.M., Binh N.T., Zelaya C.E., et al., p. 897-904.
- Syringe disposal among people who inject drugs in Los Angeles: The role of sterile syringe source. Quinn B., Chu D., Wenger L., Bluthenthal R.N., Kral A.H., p. 905-910.
- Social and economic inequalities in fatal opioid and cocaine related overdoses in Luxembourg: A case-control study. Origer A., Le Bihan E., Baumann M., p. 911-915.
- The politics of harm reduction in federal prisons. Watson T.M., p. 916-923.
- Factors associated with the use of cleaned needles and syringes among people who inject drugs in the UK: Who should we target to minimise the risks? Hope V.D., Cullen K.J., Croxford S., Parry J.V., Ncube F., p. 924-927.
- Anabolic-androgenic steroids and heroin use: A qualitative study exploring the connection. Cornford C.S., Kean J., Nash A., p. 928-930.
SPECIAL SECTION: Governance in drug policy: Evidence, stakeholders and politics
- Towards good governance in drug policy: Evidence, stakeholders and politics [Editorial]. MacGregor S., Singleton N., Trautmann F., p. 931-934.
- What is good governance in the context of drug policy? Singleton N., Rubin J., p. 935-941.
- Governance in EU illicit drugs policy. Edwards C., Galla M., p. 942-947.
- Social construction and the evidence-based drug policy endeavour. Lancaster K., p. 948-951.
- Making drug policy together: Reflections on evidence, engagement and participation. Roberts M., p. 952-956.
- Clear rhetoric and blurred reality: The development of a recovery focus in UK drug treatment policy and practice. McKeganey N., p. 957-963.
- The role of evidence and the expert in contemporary processes of governance: The case of opioid substitution treatment policy in England. Duke K., Thom B., p. 964-971.
- Drug consumption rooms and the role of politics and governance in policy processes. Houborg E., Frank V.A., p. 972-977.
- Governance versus government: Drug consumption rooms in Australia and the UK. Zampini G.F., p. 978-984.
- Making change happen: A case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction. Lancaster K., Ritter A., p. 985-991.
- Legislating thresholds for drug trafficking: A policy development case study from New South Wales, Australia. Hughes C.E., Ritter A., Cowdery N., p. 992-1000.
- Peer, professional, and public: An analysis of the drugs policy advocacy community in Europe. O’Gorman A., Quigley E., Zobel F., Moore K., p. 1001-1008.
- Legitimacy and modernity via policy transfer: The utility of the 2003 Afghan National Drug Control Strategy. Bewley-Taylor D.R., p. 1009-1018.
- Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS). Seddon T., p. 1019-1024.
- Drug policy governance in the UK: Lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act. Monaghan M., p. 1025-1030.
- Thoroughfares, crossroads and cul-de-sacs: Drug testing of welfare recipients. Wincup E., p. 1031-1037.
- Why a governance perspective could contribute to improving drug policy and engaging the international development community: Lessons from Colombia. Schultze-Kraft M., p. 1038-1039.